July 28, 2026 · Form 4 insider transaction
Sollie-Zetlmayer Hege Elisabeth bought 4,000 shares of PTC Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Restricted stock units granted on July 28, 2026, with the shares underlying such restricted stock units vesting in three equal annual installments, commencing on July 28, 2027.